Andere talen 2seventy bio, Inc.

Aandelen

TSVT

US9013841070

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 01-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
4,6 ^USD	+0,88%		+7,73%	+7,73%

19/04	Amerikaanse FDA verplicht etiketupdates voor CAR-T kankertherapieën	RE
05/04	Bristol-Myers Squibb, 2seventy Bio zeggen dat FDA uitbreiding indicatie myeloombehandeling goedkeurt	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

US FDA mandates label updates on CAR-T cancer therapies	19/04
FDA Approves BMS And J&J CAR-T Cell Therapies For The Earlier Treatment Of Multiple Myeloma	17/04
U.S. FDA Approves Bristol Myers Squibb and 2seventy bio's Abecma for Triple-Class Exposed Relapsed or Refractory Multiple Myeloma after Two Prior Lines of Therapy	08/04
Bristol-Myers Squibb, 2seventy Bio Say FDA Approves Expansion of Myeloma Treatment's Indication	05/04
Bristol Myers, 2seventy Get FDA OK for Earlier Abecma Use in Multiple Myeloma	05/04
Bristol Myers : la FDA valide Abecma dans le myélome multiple	05/04
US FDA allows expanded use of Bristol Myers' cell therapy for blood cancer	05/04
U.S. FDA allows expanded use of Bristol Myers' cell therapy	05/04
U.S. Fda Approves Bristol Myers Squibb and 2Seventy Bio?S Abecma for Triple-Class Exposed Relapsed or Refractory Multiple Myeloma After Two Prior Lines of Therapy	05/04
2seventy bio : Corporate Presentation April 2024	01/04
2seventy bio Announces Completion of Oncology and Autoimmune Pipeline Divestiture to Regeneron	01/04
Regeneron Pharmaceuticals, Inc. completed the acquiistion of R&D pipeline from 2seventy bio, Inc..	01/04
Regeneron Pharmaceuticals, Inc. completed the acquiistion of R&D pipeline from 2seventy bio, Inc. for $15 million.	01/04
Bristol Myers Squibb Gets EU OK for Cancer Treatment	20/03
Engine Capital Nominates Candidates to the Board of 2seventy bio	20/03
2seventy bio Announces Appointments of Eli Casdin and Charles Newton to Board of Directors	20/03
2seventy bio, Inc. Announces Board Appointments	20/03
Thinking about buying stock in Solidion Technology, Nuvei, 2Seventy Bio, Aeye, or DHC Acquisition?	18/03
Top Premarket Gainers	18/03
FDA Advisory Committee Votes in Favor of Bristol Myers Squibb's and 2seventy bio's Abecma for Triple-Class Exposed Multiple Myeloma in Earlier Lines of Therapy	18/03

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen 2seventy bio, Inc.

Aandelen

TSVT

US9013841070

Andere talen

Filters